Indolent NHL Panel Discussion

Dr. John Kuruvilla, Dr. Peter Anglin, Dr. Michael Crump

About Speakers

Dr. John Kuruvilla

Dr. John Kuruvilla – Princess Margaret Cancer Centre 

Dr. John Kuruvilla is an Associate Professor of Medicine at the University of Toronto and a Clinical Investigator in the Division of Medical Oncology and Hematology at Princess Margaret Hospital in Toronto. He is a hematologist and member of the Lymphoma Program and the Autologous Blood and Marrow Transplant program. Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.

Dr. Peter Anglin

Dr. Peter Anglin – Stronach Regional Cancer Centre

Dr. Peter Anglin obtained his medical degree from Queen’s University at Kingston and followed this with clinical fellowships in internal medicine, hematology and oncology. He has been in clinical practice for the last 21 years in the Greater Toronto Area and is currently a staff Hematologist/Medical Oncologist and Physician Lead at the Stronach Regional Cancer Centre at Southlake Health in Newmarket, Ontario. Dr. Anglin’s clinical focus has been in hematologic and lymphoid malignancies. After pursuing an MBA from the Rotman School of Management (University of Toronto) he has developed an interest in health systems delivery and process redesign in the clinical ambulatory setting.

Dr. Michael Crump – Princess Margaret Cancer Centre

Michael Crump is a hematologist in the Division of Medical Oncology and Hematology at Princess Margaret Cancer Centre, and Professor of Medicine at the University of Toronto. His clinical and research interests are primary and second line therapy of lymphoid malignancies, investigation of novel therapies and in autologous stem cell transplantation. He is currently the Co-Chair of the Hematology Disease Site Group and the Lymphoma Working Group Chair for the Canadian Cancer Trials Group (CCTG).

Thank you to our WHU 2021 Sponsors